ENDS --:--:--Ion PeptideIon Peptide — Buy 2 get 1 - stackable with VIALTALK for additional 15% offShop Now
ENDS --:--:--Studz AminosStudz birthday bashStudz Aminos — buy 2 get 1 - buy 5 get 3 - buy 2 kits get 1 50% off - buy 5 kits get 2Shop Now
VialTalk
Phase One Labz logo

Amylin Agonist + Triple Agonist 12.5mg — Verification Report

From Phase One Labz · Lot ELORT1 · Tested September 2026

← Back to Phase One Labz
VialTalk
Verification report

Amylin Agonist + Triple Agonist 12.5mg

Phase One Labz

Score
106.5
Grade
A++
Superlative
Cap color: Unresolved(not recorded; the report and the submitter did not confirm it)
Lot ELORT1
Tested September 2026
Report ID
c6585c87
PurityFull credit
HPLC
99.88%
IdentityFull credit
Mass spectrometry
Confirmed
ContentFull credit
Gravimetric vs label claim · tested weight disclosed and verified
12.5 mg labeled · 14.17 mg tested
EndotoxinFull credit
USP <85> compendial
Pass (lab reported)
Heavy metalsFull credit
USP <232>/<233> compendial
Screened
SterilityPartial
PCR / DNA microarray
Screened
Batch conformityPartial
Two-batch average
Assessed
Additional screens, not scoredFentanyl screen

Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted. Scores above 100 reflect laboratory credibility weighting.

This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →